Connected Injectable Drug Delivery Devices Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017-2021 and Forecast 2022-2028

$ PRICE - $ 3,000.00$ 8,900.00

Connected Injectable Drug Delivery Devices Market By Device Type (Connected sensors, Integrated devices), By Technology (Bluetooth, Near field communication, Service), By Application (Anaphylaxis, Respiratory, Cardiovascular, Diabetes, Hormone Replacement, Others), By End User (Hospital, Clinics, Homecare, Others), and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Category:

Report

Description

Connected Injectable Drug Delivery Devices Market size valued USD 397.2 million in 2021 and expected to reach USD 4,468.9 million by 2028, exhibiting a CAGR of 35.4% during the forecast period 2022-2028. The prevalence of chronic diseases is likely to affect the growth of the market size of the connected drug delivery devices. Continuous product innovation, multiple products in pipeline and mergers, and joint initiatives are some factors that help increase market share across the map for connected drug delivery devices. At the same time, problems arising from excessive use of nasal sprays could limit the growth of the market. In addition, local side effects risk, and decreased bioavailability are also factors that hamper market development. This study analyses the global connected injectable drug delivery devices market dynamics in a detailed manner to identify current trends and drivers, growth opportunities and potential challenges to the key stakeholders in the operating market. In addition, PBI has analyzed the global market to better equip customers with possible investment opportunities across regions and consumer unmet needs. Key stakeholders of the global assisted reproductive technology include suppliers, manufacturers, marketers, policymakers, and service providers engaged in the global assisted reproductive technology market.

Connected Injectable Drug Delivery Devices Market

MARKET SUMMARY
-
35.4%
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 35.4%
  • Largest Market– Asia-Pacific
  • Fastest Growing Market– North-America

Connected Injectable Drug Delivery Devices Market

  • The global connected injectable drug delivery devices market report gives a comprehensive outlook on brain monitoring across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa.
  • The report on the global connected injectable drug delivery devices market gives historical, current, and future market sizes (US$ Mn) on the basis of vehicle, by films, channel and region.
Key Players
  • Ypsomed Holdings
  • Unolife Corporation
  • Quio Technologies
  • Phillips-Medisize Corporation
  • SHL Group
Connected Injectable Drug Delivery Devices Market

Growing population of patients and rising unmet medical needs, increasing demand for healthcare services, result in increased cost pressure on global healthcare systems. This is expected to boost the global demand for connected injectable drug delivery devices in the coming years. For example, rheumatoid arthritis (RA) affected more than 1.5 million people in the U.S. in 2017, according to the American Arthritis Association. Similarly, a rise in the incidence of diabetes is projected to drive the global demand for connected injectable drug delivery devices in the immediate future.


North-America Got Significant Share

Connected Injectable Drug Delivery Devices Market

Owing to technological developments in the pharmaceutical industry and a high rate of product adoption in the region, North America dominates the global market for injectable drug delivery devices. Asia Pacific is expected to be the most lucrative market for connected injectable drug delivery devices in the near future, owing to ongoing medical infrastructure growth, increased adoption of technologically advanced surgical procedures and increased government initiatives in the region.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Developments

  • In October 2019, Phillips-Medisize- a Molex Company, announced the projected launch of its first electronic-enabled drug delivery devices. According to the announcement, the company is expected to launch its product in the second half of 2020.
  • In January 2019, FindAir, a European company launched their smart inhaler, FindAir ONE in the Europe market. The device is intended to offer treatment for patients suffering from COPD and Asthma.
Connected Injectable Drug Delivery Devices Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

The connected injectable drug delivery devices market is projected to expand at a CAGR of 5.5% during the forecast period

 

Ypsomed Holdings, Unolife Corporation, Quito Technologies, Phillips-Medisize Corporation, SHL Group

North America is the fastest-growing region for connected injectable drug delivery devices market


Report

Table Of Content

1. Executive Summary
2. Global Connected Injectable Drug Delivery Devices Market Introduction
2.1. Global Connected Injectable Drug Delivery Devices Market – Taxonomy
2.2. Global Connected Injectable Drug Delivery Devices Market –Definitions
2.2.1. By Device Type
2.2.2. By Technology
2.2.3. By Application
2.2.4. By End User
2.2.5. By Region
3. Global Connected Injectable Drug Delivery Devices Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Connected Injectable Drug Delivery Devices Market Dynamic Factors – Impact Analysis
3.6. Global Connected Injectable Drug Delivery Devices Market – Competition Landscape
4. Global Connected Injectable Drug Delivery Devices Market Analysis, 2017-2021 and Forecast, 2022-2028
4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Connected Injectable Drug Delivery Devices Market, By Device Type, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1. Connected Sensors
5.1.1. Connected inhalation sensors
5.1.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.1.3. Market Opportunity Analysis
5.1.2. Connected injectable sensors
5.1.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.2.3. Market Opportunity Analysis
5.2. Integrated Devices
5.2.1. Integrated inhalation devices
5.2.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.2.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.1.3. Market Opportunity Analysis
5.2.2. Integrated injectable devices
5.2.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.2.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.2.3. Market Opportunity Analysis
6. Global Connected Injectable Drug Delivery Devices Market, By Technology, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1. Bluetooth
6.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Near Field Communication
6.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Service
6.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
7. Global Connected Injectable Drug Delivery Devices Market, By Application, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1. Anaphylaxis
7.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Respiratory
7.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Cardiovascular
7.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Diabetes
7.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Hormone Replacement
7.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
7.6. Others
7.6.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.6.3. Market Opportunity Analysis
8. Global Connected Injectable Drug Delivery Devices Market, By End User, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.1. Hospital
8.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Clinic
8.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Homecare
8.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Others
8.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
9. Global Connected Injectable Drug Delivery Devices Market Forecast, By Region, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.1. North America
9.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
9.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
9.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.5.3. Market Opportunity Analysis
9.6. Global Connected Injectable Drug Delivery Devices Market – Opportunity Analysis Index, By Device Type, By Technology, By Application, By End User, and Region, 2022-2028
10. North America Connected Injectable Drug Delivery Devices Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
10.1. Device Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Connected sensors
10.1.1.1. Connected inhalation sensors
10.1.1.2. Connected injectable sensors
10.1.2. Integrated devices
10.1.2.1. Integrated inhalation devices
10.1.2.2. Integrated injectable devices
10.2. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.2.1. Bluetooth
10.2.2. Near field communication
10.2.3. Service
10.3. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Anaphylaxis
10.3.2. Respiratory
10.3.3. Cardiovascular
10.3.4. Diabetes
10.3.5. Hormone Replacement
10.3.6. Others
10.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.4.1. Hospital
10.4.2. Clinics
10.4.3. Homecare
10.4.4. Others
10.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.5.1. USA
10.5.2. Canada
10.6. North America Connected Injectable Drug Delivery Devices Market – Opportunity Analysis Index, By Device Type, By Technology, By Application, By End User, and Country, 2022-2028
10.7. North America Connected Injectable Drug Delivery Devices Market Dynamics – Trends
11. Europe Connected Injectable Drug Delivery Devices Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
11.1. Device Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Connected sensors
11.1.1.1. Connected inhalation sensors
11.1.1.2. Connected injectable sensors
11.1.2. Integrated devices
11.1.2.1. Integrated inhalation devices
11.1.2.2. Integrated injectable devices
11.2. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.2.1. Bluetooth
11.2.2. Near field communication
11.2.3. Service
11.3. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Anaphylaxis
11.3.2. Respiratory
11.3.3. Cardiovascular
11.3.4. Diabetes
11.3.5. Hormone Replacement
11.3.6. Others
11.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.4.1. Hospital
11.4.2. Clinics
11.4.3. Homecare
11.4.4. Others
11.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.5.1. Germany
11.5.2. UK
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Russia
11.5.7. Rest of Europe
11.6. Europe Connected Injectable Drug Delivery Devices Market – Opportunity Analysis Index, By Device Type, By Technology, By Application, By End User, and Country, 2022-2028
11.7. Europe Connected Injectable Drug Delivery Devices Market Dynamics – Trends
12. Asia-Pacific Connected Injectable Drug Delivery Devices Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
12.1. Device Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Connected sensors
12.1.1.1. Connected inhalation sensors
12.1.1.2. Connected injectable sensors
12.1.2. Integrated devices
12.1.2.1. Integrated inhalation devices
12.1.2.2. Integrated injectable devices
12.2. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.2.1. Bluetooth
12.2.2. Near field communication
12.2.3. Service
12.3. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Anaphylaxis
12.3.2. Respiratory
12.3.3. Cardiovascular
12.3.4. Diabetes
12.3.5. Hormone Replacement
12.3.6. Others
12.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.4.1. Hospital
12.4.2. Clinics
12.4.3. Homecare
12.4.4. Others
12.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.5.1. China
12.5.2. India
12.5.3. Japan
12.5.4. ASEAN
12.5.5. Australia & New Zealand
12.5.6. Rest of Asia-Pacific
12.6. Asia-Pacific Connected Injectable Drug Delivery Devices Market – Opportunity Analysis Index, By Device Type, By Technology, by Device Type, By End User, and Country, 2022-2028
12.7. Asia-Pacific Connected Injectable Drug Delivery Devices Market Dynamics – Trends
13. Latin America Connected Injectable Drug Delivery Devices Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
13.1. Device Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Connected sensors
13.1.1.1. Connected inhalation sensors
13.1.1.2. Connected injectable sensors
13.1.2. Integrated devices
13.1.2.1. Integrated inhalation devices
13.1.2.2. Integrated injectable devices
13.2. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.2.1. Bluetooth
13.2.2. Near field communication
13.2.3. Service
13.3. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Anaphylaxis
13.3.2. Respiratory
13.3.3. Cardiovascular
13.3.4. Diabetes
13.3.5. Hormone Replacement
13.3.6. Others
13.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.4.1. Hospital
13.4.2. Clinics
13.4.3. Homecare
13.4.4. Others
13.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Latin America Connected Injectable Drug Delivery Devices Market – Opportunity Analysis Index, By Device Type, By Technology, By Application, By End User, and Country, 2022-2028
13.7. Latin America Connected Injectable Drug Delivery Devices Market Dynamics – Trends
14. Middle East and Africa Connected Injectable Drug Delivery Devices Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
14.1. Device Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.1. Connected sensors
14.1.1.1. Connected inhalation sensors
14.1.1.2. Connected injectable sensors
14.1.2. Integrated devices
14.1.2.1. Integrated inhalation devices
14.1.2.2. Integrated injectable devices
14.2. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.2.1. Bluetooth
14.2.2. Near field communication
14.2.3. Service
14.3. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.3.1. Anaphylaxis
14.3.2. Respiratory
14.3.3. Cardiovascular
14.3.4. Diabetes
14.3.5. Hormone Replacement
14.3.6. Others
14.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.4.1. Hospital
14.4.2. Clinics
14.4.3. Homecare
14.4.4. Others
14.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
14.5.1. Gulf CoEnd User Council (GCC) Countries
14.5.2. South Africa
14.5.3. Rest of MEA
14.6. MEA Connected Injectable Drug Delivery Devices Market – Opportunity Analysis Index, By Device Type, By Technology, By Application, By End User, and Country, 2022-2028
14.7. MEA Connected Injectable Drug Delivery Devices Market Dynamics – Trends
15. Competition Landscape 
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Key Device Types, Key Developments, Strategies, and SWOT Analysis)
15.2.1. Ypsomed Holdings
15.2.2. Unolife Corporation
15.2.3. Quio Technologies
15.2.4. Phillips-Medisize Corporation
15.2.5. SHL Group
15.2.6. Biocorp
15.2.7. Haselmeier Inc.
15.2.8. West Pharmaceutical Services Inc.
16. Research Methodology
17.Key Assumptions and Acronyms

Report

Company Profile

  • Ypsomed Holdings
  • Unolife Corporation
  • Quio Technologies
  • Phillips-Medisize Corporation
  • SHL Group
  • Biocorp
  • Haselmeier Inc.
  • West Pharmaceutical Services Inc.

Description

Connected Injectable Drug Delivery Devices Market size valued USD 397.2 million in 2021 and expected to reach USD 4,468.9 million by 2028, exhibiting a CAGR of 35.4% during the forecast period 2022-2028. The prevalence of chronic diseases is likely to affect the growth of the market size of the connected drug delivery devices. Continuous product innovation, multiple products in pipeline and mergers, and joint initiatives are some factors that help increase market share across the map for connected drug delivery devices. At the same time, problems arising from excessive use of nasal sprays could limit the growth of the market. In addition, local side effects risk, and decreased bioavailability are also factors that hamper market development. This study analyses the global connected injectable drug delivery devices market dynamics in a detailed manner to identify current trends and drivers, growth opportunities and potential challenges to the key stakeholders in the operating market. In addition, PBI has analyzed the global market to better equip customers with possible investment opportunities across regions and consumer unmet needs. Key stakeholders of the global assisted reproductive technology include suppliers, manufacturers, marketers, policymakers, and service providers engaged in the global assisted reproductive technology market.

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX